Healthcare - Biotechnology - NASDAQ - US
$ 2.19
11.7 %
$ 9.56 M
Market Cap
-0.15
P/E
CASH FLOW STATEMENT
-10.3 M
OPERATING CASH FLOW
0
INVESTING CASH FLOW
10.4 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
SeaStar Medical Holding Corporation
| Net Income | -26.2 M |
| Depreciation & Amortization | 14 M |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 1.93 M |
| Change in Working Capital | 2.88 M |
| Others | 11.6 M |
| Free Cash Flow | -10.3 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | |
|---|---|---|---|---|
| OPERATING CASH FLOW | ||||
| Net Income | (26.2) | (23.0) | (4.6) | (3.3) |
| Depreciation & Amortization | 0 | 0 | 0 | 0 |
| Deferred Income Tax | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 1.9 | 1.3 | 14 K | 16 |
| Other Operating Activities | 11.1 | 11.4 | 0.1 | (3.2) |
| Change in Working Capital | 2.9 | 2.6 | (0.7) | 0.9 |
| Cash From Operations | (10.3) | (7.8) | (5.1) | (5.6) |
| INVESTING CASH FLOW | ||||
| Capital Expenditures | 0 | 0 | 0 | 0 |
| Other Items | 0 | 0 | (105.6) | 0 |
| Cash From Investing Activities | 0 | 0 | (105.6) | 0 |
| FINANCING CASH FLOW | ||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 3.5 | 3.5 | 2.8 | (0.1) |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0.3 | (6.2) | 0 | 10.1 |
| Cash From Financing Activities | 10.4 | 7.3 | 2.8 | 4.9 |
| CHANGE IN CASH | ||||
| Net Change In Cash | 0.1 | (0.5) | (2.3) | (0.7) |
| FREE CASH FLOW | ||||
| Free Cash Flow | (10.3) | (7.8) | (5.1) | (5.6) |